BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 34478686)

  • 1. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
    Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
    Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures.
    Ito Y; Carss KJ; Duarte ST; Hartley T; Keren B; Kurian MA; Marey I; Charles P; Mendonça C; Nava C; Pfundt R; Sanchis-Juan A; van Bokhoven H; van Essen A; van Ravenswaaij-Arts C; ; ; Boycott KM; Kernohan KD; Dyack S; Raymond FL
    Am J Hum Genet; 2018 Jul; 103(1):144-153. PubMed ID: 29961568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrent WASF1 nonsense variant identified in two unaffected Chinese families with neurodevelopmental disorder: case report and review of the literatures.
    Tang X; Liu G; Lin L; Xiao N; Chen Y
    BMC Med Genomics; 2023 Aug; 16(1):203. PubMed ID: 37641121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED13 mutation: A novel cause of developmental and epileptic encephalopathy with infantile spasms.
    Trivisano M; De Dominicis A; Micalizzi A; Ferretti A; Dentici ML; Terracciano A; Calabrese C; Vigevano F; Novelli G; Novelli A; Specchio N
    Seizure; 2022 Oct; 101():211-217. PubMed ID: 36087421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of the Genotypic and Phenotypic Spectrum of WASF1-Related Neurodevelopmental Disorder.
    Srivastava S; Macke EL; Swanson LC; Coulter D; Klee EW; Mullegama SV; Xie Y; Lanpher BC; Bedoukian EC; Skraban CM; Villard L; Milh M; Leppert MLO; Cohen JS
    Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures.
    Zweier M; Begemann A; McWalter K; Cho MT; Abela L; Banka S; Behring B; Berger A; Brown CW; Carneiro M; Chen J; Cooper GM; ; Finnila CR; Guillen Sacoto MJ; Henderson A; Hüffmeier U; Joset P; Kerr B; Lesca G; Leszinski GS; McDermott JH; Meltzer MR; Monaghan KG; Mostafavi R; Õunap K; Plecko B; Powis Z; Purcarin G; Reimand T; Riedhammer KM; Schreiber JM; Sirsi D; Wierenga KJ; Wojcik MH; Papuc SM; Steindl K; Sticht H; Rauch A
    Eur J Hum Genet; 2019 May; 27(5):747-759. PubMed ID: 30664714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent de novo pathogenic variant of WASF1 in a Japanese patient with neurodevelopmental disorder with absent language and variable seizures.
    Shimojima Yamamoto K; Yanagishita T; Yamamoto H; Miyamoto Y; Nagata M; Ishihara Y; Miyashita Y; Asano Y; Sakata Y; Yamamoto T
    Hum Genome Var; 2021 Nov; 8(1):43. PubMed ID: 34845217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.
    Schoch K; Meng L; Szelinger S; Bearden DR; Stray-Pedersen A; Busk OL; Stong N; Liston E; Cohn RD; Scaglia F; Rosenfeld JA; Tarpinian J; Skraban CM; Deardorff MA; Friedman JN; Akdemir ZC; Walley N; Mikati MA; Kranz PG; Jasien J; McConkie-Rosell A; McDonald M; Wechsler SB; Freemark M; Kansagra S; Freedman S; Bali D; Millan F; Bale S; Nelson SF; Lee H; Dorrani N; ; ; Goldstein DB; Xiao R; Yang Y; Posey JE; Martinez-Agosto JA; Lupski JR; Wangler MF; Shashi V
    Am J Hum Genet; 2017 Feb; 100(2):343-351. PubMed ID: 28132692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Infantile Epileptic Encephalopathy with a de novo variant in ZEB2 identified by exome sequencing.
    Babkina N; Deignan JL; Lee H; Vilain E; Sankar R; Giurgea I; Mowat D; Graham JM
    Eur J Med Genet; 2016 Feb; 59(2):70-4. PubMed ID: 26721324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of a de novo c.2605C > T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability.
    Yi Z; Zhang Y; Song Z; Pan H; Yang C; Li F; Xue J; Qu Z
    Ital J Pediatr; 2020 Jul; 46(1):95. PubMed ID: 32646507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
    Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
    Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early infantile epileptic encephalopathy caused by PACS2 gene variation: three cases report and literature review].
    Wu MJ; Hu CH; Ma JH; Hu JS; Liu ZS; Sun D
    Zhonghua Er Ke Za Zhi; 2021 Jul; 59(7):594-599. PubMed ID: 34405643
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
    Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
    Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.
    Prchalova D; Havlovicova M; Sterbova K; Stranecky V; Hancarova M; Sedlacek Z
    BMC Med Genet; 2017 Jun; 18(1):62. PubMed ID: 28576131
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Chen S; Deng X; Xiong J; Chen B; He F; Yang L; Yang L; Peng J; Yin F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):265-270. PubMed ID: 35545418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay.
    Cai S; Li J; Wu Y; Jiang Y
    J Hum Genet; 2020 Jul; 65(7):601-608. PubMed ID: 32203252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent de novo CUX2 missense variant associated with intellectual disability, seizures, and autism spectrum disorder.
    Barington M; Risom L; Ek J; Uldall P; Ostergaard E
    Eur J Hum Genet; 2018 Sep; 26(9):1388-1391. PubMed ID: 29795476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.